|
ZNF713 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.206900E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.799740E-02 |
| Normal-vs-Stage2 |
3.021000E-03 |
| Normal-vs-Stage3 |
5.35199999873726E-08 |
| Normal-vs-Stage4 |
3.29290000045113E-07 |
| Stage1-vs-Stage2 |
2.458400E-01 |
| Stage1-vs-Stage3 |
3.773000E-04 |
| Stage1-vs-Stage4 |
6.430700E-04 |
| Stage2-vs-Stage3 |
8.809900E-02 |
| Stage2-vs-Stage4 |
7.924500E-02 |
| Stage3-vs-Stage4 |
8.296400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.26330000002917E-06 |
| Normal-vs-AfricanAmerican |
5.852800E-01 |
| Normal-vs-Asian |
7.353200E-01 |
| Caucasian-vs-AfricanAmerican |
1.079440E-01 |
| Caucasian-vs-Asian |
2.063600E-01 |
| AfricanAmerican-vs-Asian |
9.339200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.595900E-04 |
| Normal-vs-Female |
1.837080E-04 |
| Male-vs-Female |
9.551800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.484200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.014820E-04 |
| Normal-vs-Age(61-80Yrs) |
5.237000E-04 |
| Normal-vs-Age(81-100Yrs) |
1.10919999962711E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.324200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.934400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.408100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.934200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.922890E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.184600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.646600E-01 |
| Normal-vs-Grade 2 |
2.960100E-02 |
| Normal-vs-Grade 3 |
1.27790000026273E-07 |
| Normal-vs-Grade 4 |
4.78539999848593E-08 |
| Grade 1-vs-Grade 2 |
1.976980E-01 |
| Grade 1-vs-Grade 3 |
8.210400E-02 |
| Grade 1-vs-Grade 4 |
6.388000E-02 |
| Grade 2-vs-Grade 3 |
5.57860000000021E-05 |
| Grade 2-vs-Grade 4 |
2.39369999999184E-05 |
| Grade 3-vs-Grade 4 |
2.575800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.43610000000483E-05 |
| Normal-vs-ccB subtype |
9.019600E-03 |
| ccA subtype-vs-ccB subtype |
4.430200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.754500E-04 |
| Normal-vs-N1 |
2.35459999999854E-05 |
| N0-vs-N1 |
1.833770E-02 |
|
|
